Cargando…

The Heart Failure Optimization Study (HF-OPT): rationale and design

BACKGROUND: According to the current guidelines, implantable cardioverter-defibrillators (ICD) for primary prevention in patients with heart failure and reduced ejection fraction (HFrEF) should not be considered until optimal guideline-directed medical therapy (GDMT) has been achieved for a minimum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez, R., Duncker, D., Colley, B., Doering, M., Gummadi, S., Perings, C., Robertson, M., Shroff, G., Veltmann , C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2023
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950163/ https://www.ncbi.nlm.nih.gov/pubmed/36695885 http://dx.doi.org/10.1007/s00399-022-00920-5

Ejemplares similares

Publisher Erratum: The Heart Failure Optimization Study (HF‑OPT): rationale and design
por: Sanchez, R., et al.
Publicado: (2023)

Regional management of worsening heart failure: rationale and design of the CHAIN‐HF registry
por: Shakoor, Abdul, et al.
Publicado: (2023)

Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
por: Duncker, David, et al.
Publicado: (2018)

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) trial
por: Keene, Daniel, et al.
Publicado: (2018)

Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design
por: Lainscak, Mitja, et al.
Publicado: (2019)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
por: Correale, Michele, et al.
Publicado: (2023)

Antiarrhythmic effects of baroreceptor activation therapy in chronic heart failure: a case report
por: Wang, Dong, et al.
Publicado: (2023)

The role of the relatives in opt-in systems of postmortal organ procurement
por: den Hartogh, Govert
Publicado: (2011)

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
por: von Haehling, Stephan, et al.
Publicado: (2010)

Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF
por: De Ferrari, Gaetano M, et al.
Publicado: (2014)

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
por: Bavendiek, Udo, et al.
Publicado: (2019)

Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
por: Wang, Michael C., et al.
Publicado: (2021)

Detecting Heart Failure Decompensation by Measuring Transthoracic Bioimpedance in the Outpatient Setting: Rationale and Design of the SENTINEL-HF Study
por: Dovancescu, Silviu, et al.
Publicado: (2015)

Design and Rationale of the National Tunisian Registry of Heart Failure (NATURE-HF): Protocol for a Multicenter Registry Study
por: Abid, Leila, et al.
Publicado: (2021)

Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial
por: Störk, Stefan, et al.
Publicado: (2022)

Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
por: Wang, Michael C., et al.
Publicado: (2022)

Rationale and Design of Heart Failure Prevalence and Evolution of Heart Failure in Diabetes Mellitus Type II Patients at High Risk (HF-LanDMark Study)
por: Parissis, John, et al.
Publicado: (2023)

Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry
por: Woehrle, Holger, et al.
Publicado: (2014)

Rationale and design of a risk‐guided strategy for reducing readmissions for acute decompensated heart failure: the Risk‐HF study
por: Zisis, Georgios, et al.
Publicado: (2020)

Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands: Design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry
por: Brugts, J. J., et al.
Publicado: (2018)

Genetic and ElectroNic medIcal records to predict oUtcomeS in Heart Failure patients (GENIUS-HF) - design and rationale
por: Gioli-Pereira, Luciana, et al.
Publicado: (2014)

The inorganic NItrate and eXercise performance in Heart Failure (iNIX-HF) phase II clinical trial: Rationale and study design
por: Coggan, Andrew R., et al.
Publicado: (2023)

Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2021)

Noninvasive imaging assessment of rehabilitation therapy in heart failure with preserved and reduced left ventricular ejection fraction (IMAGING-REHAB-HF): design and rationale
por: Cardoso, Fernando Bianchini, et al.
Publicado: (2019)

Clinical Value of Novel Echocardiographic Biomarkers Assessing Myocardial Work in Acute Heart Failure—Rationale and Design of the “Beyond Myo-HF Study”
por: Anastasiou, Vasileios, et al.
Publicado: (2023)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics)
por: Pascual, Carlos Rodríguez, et al.
Publicado: (2011)

Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD)
por: McCallum, Linsay, et al.
Publicado: (2020)

Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronization
por: Yan, Ji, et al.
Publicado: (2018)

Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial
por: Bavendiek, Udo, et al.
Publicado: (2023)

Opt art: from mathematical optimization to visual design
por: Bosch, Robert
Publicado: (2019)

Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial
por: Li, Yi, et al.
Publicado: (2020)

Geographic variations in the PARADIGM-HF heart failure trial
por: Kristensen, Søren Lund, et al.
Publicado: (2016)

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry
por: Filippatos, Gerasimos, et al.
Publicado: (2015)

Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE‐ASIA‐HF)
por: Yeo, Tee Joo, et al.
Publicado: (2015)

The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Rationale and Design of the Effect of Ivabradine on Exercise Tolerance in Patients With Chronic Heart Failure (EXCILE-HF) Trial　― Protocol for a Multicenter Randomized Controlled Trial ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2023)

The genomics of heart failure: design and rationale of the HERMES consortium
por: Lumbers, R. Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_os82pa0oslmb375qe0cigd46pp